Skip to main content
  • Revascularization Still Shows No Benefit vs. Conservative Strategy in Stable CAD Patients with Advanced CKD at 5 Years – ISCHEMIA-CKD EXTEND

    Patients with advanced chronic kidney disease (CKD) and at least moderate ischemia on stress testing showed high rates of both all-cause and cardiovascular mortality at 5-year follow-up of the randomized ISCHEMIA-CKD trial, while the trial’s initial comparative strategies – invasive vs. conservative – continued to show no significant difference in survival rates, new results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details